Benzoic Acid

Benzoic Acid

SCHEMBL6250252

O=C(O)c1ccc2cc1-2.O=C(O)c1ccccc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.56
TSHR P16473 1/20 0.56
NAPRT Q6XQN6 1/20 0.56
DDT P30046 1/20 0.53
CYP2C8 P10632 2/20 0.52
CYP2C9 P11712 1/20 0.52
KDM4E B2RXH2 1/20 0.52
ACMSD Q8TDX5 2/20 0.48
HNF4A P41235 1/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
SRD5A2 P31213 1/20 0.48
EGFR P00533 1/20 0.47
KMO O15229 1/20 0.47
PLA2G2A P14555 1/20 0.47
PTPN1 P18031 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
AKR1C3 P42330 1/20 0.45
MAP4K4 O95819 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460360 0.87 ACMSD (0.58) ACMSDHNF4AEGFRKMOPTPN1
Benzoic Acid SCHEMBL3778226 0.84 CYP2C8 (0.56) DAOTSHRNAPRTCYP2C8CYP2C9
SCHEMBL30462310 0.84 DDT (0.49) TSHRDDTKDM4EPTPN1
SCHEMBL10334618 0.83 ACMSD (0.62) KDM4EACMSDHNF4APTPN1AKR1C3
Terephthalic Acid SCHEMBL28437947 0.82 KDM4E (0.55) DAOTSHRNAPRTDDTCYP2C8
SCHEMBL2462821 0.82 ACMSD (0.66) ACMSDHNF4AKMOPTPN1NPC1
SCHEMBL599317 0.82 FOLH1 (0.53) TSHRDDTCYP2C8KDM4ESRD5A2
SCHEMBL6422582 0.81 CYP1A2 (0.44) TSHRDDTKDM4EACMSDHNF4A
SCHEMBL10782352 0.81 DDT (0.67) DDTKDM4EKMOPLA2G2APTPN1
SCHEMBL30777933 0.81 HNF4A (0.55) DDTKDM4EACMSDHNF4AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399458-B1 AN ARYLATION METHOD FOR THE FUNCTIONALIZATION OF O-ALLYL ERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2005-08-03 EP claimed
CN-113710710-A Method for producing propylene polymer 住友化学株式会社 2021-11-26 CN disclosed
EP-3419987-A1 AFFINITY LIGAND FOR THE PURIFICATION OF GLYCOSYLATED BIOMOLECULES Hochschule für Technik und Wirtschaft (HTW) Berlin (DE) 2019-01-02 EP disclosed
WO-2017144099-A1 AFFINITY LIGAND FOR THE PURIFICATION OF GLYCOSYLATED BIOMOLECULES HOCHSCHULE FÜR TECHNIK UND WIRTSCHAFT (HTW) BERLIN (DE) 2017-08-31 WO disclosed
US-5254676-A Oligosaccharide inhibitors for influenza virus E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-10-19 US disclosed
US-5220008-A Oligosaccharide inhibitors for influenza virus E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-06-15 US disclosed
US-5026898-A Cell process controllers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-06-25 US disclosed
US-4924023-A MEDICINE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-05-08 US disclosed
US-4873355-A Process for regioselectively preparing phosphorylated inositols and other cyclitols E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-10-10 US disclosed